Influenza virus binding to host cells and neutrophil trafficking to sites of inflammation are diverse aspects of biology mediated by receptor recognition of sialic acids that terminate glycans on cell surface glycoproteins and glycolipids. The first crystal structure of a mammalian sialyltransferase provides insights into the biosynthesis of the rich spectrum of sialic acid-containing glycans in the mammalian glycome.
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Influenza virus binding to host cells and neutrophil trafficking to sites of inflammation are diverse aspects of biology mediated by receptor recognition of sialic acids that terminate glycans on cell surface glycoproteins and glycolipids. The first crystal structure of a mammalian sialyltransferase provides insights into the biosynthesis of the rich spectrum of sialic acid-containing glycans in the mammalian glycome.
Sialic acids occupy the terminal position of glycan chains of glycoproteins and glycolipids and contribute to the huge range of glycan structures that mediate cell surface biology. They are recognized as ligands by mammalian glycan-binding proteins and as receptors for pathogens such as influenza and polyoma virus, bacteria and many bacterial toxins as they attach to the host cell 1 .
Several mammalian glycan-binding proteins that use sialic acid-containing glycans (sialosides) as cell surface ligands are well documented to mediate aspects of immune cell biology. Notably, the selectin subgroup of the C-type lectins mediate leukocyte trafficking to lymph nodes and inflammation sites 2 , and the family of sialic acid-binding immunoglobulin-like lectins (siglecs) are differentially expressed on white blood cells and modulate cell-signaling receptors involved in innate and adaptive immune responses 3 .
The biosynthesis of sialosides is carried out by a family of 20 sialyltransferases that are highly conserved from mouse to man (Fig. 1a) 4, 5 . These enzymes transfer sialic acid from a donor substrate, CMP-sialic acid, to terminal positions of the glycan chains of glycoproteins. In keeping with the role of sialyltransferases as 'glycan terminators', they are located at the end of the secretory pathway in the trans-Golgi network, through which glycoproteins and glycolipids pass enroute to the cell surface or to secretion from the cell.
Unlike the biosyntheses of DNA, RNA and proteins, which use a nucleic acid sequence as a template, the fidelity of glycan biosynthesis relies on the specificity of glycosyltransferases for their acceptor substrates. Each sialyltransferase has a strict specificity for the acceptor sequence that distinguishes its substrate from other glycan sequences, and each transfers sialic acid in a defined linkage to yield a specific product that terminates the synthesis of the glycan chain. Sialyltransferases are grouped into four subfamilies based on the linkage formed in the adduct (for example, Neu5Acα2-6Gal; Fig. 1a) . A further level of control of sialoside synthesis is added by the cell type-specific and developmentally regulated expression of sialyltransferase genes 6 ; therefore, different sialic acid subgroups are present depending on the presence of the corresponding enzymes. 
the specificity of ST3Gal-I for the disaccharide sequence Galβ1-3GalNAc. Tyr269 achieves this by making the crucial contacts to the axial C4 positions of both Gal and GalNAc moieties. The authors also note a polar groove adjacent to the acceptor site that can accommodate a peptide or lipid moiety that extends from the disaccharide acceptor substrate in the natural ligands of the enzyme. These observations pave the way for a closer look at the bases for the substrate specificities of other members of the subfamily as their structures become available.
Genetic ablation of sialyltransferase genes in mice produced phenotypes that show the importance of the products of these enzymes in modulating many aspects of immune function and blood coagulation 11 . Such observations have stimulated interest in these enzymes as targets for development of drugs to treat autoimmune diseases and coagulopathies. The availability of the high-resolution ST3Gal-I structure reported by Rao et al. is sure to stimulate efforts toward the rational design of small-molecule inhibitors of this important family of enzymes. motifs frame the catalytic site, and a disulfide bond stabilizes the two sialyl motifs (large, L, and small, S), a feature conserved throughout the sialyltransferase family 5 . A flexible loop missing from the electron density is proposed to form a 'lid domain' that participates in the binding of the donor substrate.
The structure of ST3Gal-I is also informative with respect to the general fold and catalytic mechanism of the sialyltransferase family. Glycosyltransferases in general fall into two main fold groupings, designated GT-A and GT-B, with one and two Rossman-like domains, respectively 9 . The structures of ST3Gal-I and a bacterial sialyltransferase 10 , previously solved by the same group, are variants of the GT-A fold, and both have the spatial arrangement of a β-sheet core structure. Sialyltransferases are known to be 'inverting' glycosyltransferases because the Neu5Ac in the donor substrate (CMP-β-Neu5Ac) is in the β configuration, whereas it is in α configuration in the product (Neu5Acα2-3Gal). On the basis of the placement of the donor and acceptor substrates in the catalytic sites of the mammalian and bacterial sialyltransferases, the authors propose that the reaction mechanism of ST3Gal-I proceeds through an oxocarbenium-ion transition state, with His319 in the conserved very small (VS) sialyl motif as the catalytic base 7, 10 .
Although all sialyltransferases use CMPNeu5Ac as a donor substrate, they vary in their specificity for acceptor substrates. The ability to distinguish between acceptor substrates is the defining property that allows glycosyltransferases to build a glycan of defined sequence in the absence of a template. Indeed, even sialyltransferases of the same ST3Gal subfamily differentiate between disaccharide acceptors with a β1-3 or β1-4 glycosidic linkage and/or disaccharide sequence. The This diversity contributes to the rich biology mediated by this class of glycan sequences.
In this issue, Rao et al. 7 describe the structure of a mammalian sialyltransferase, ST3Gal-I (Fig. 1b) . This enzyme catalyzes the synthesis of the sequence NeuAcα2-3Galβ1-3GalNAc, which is found O-linked to threonine or serine on glycoproteins and as a terminal sequence of the ganglio-series of glycolipids. Although its activity is partially redundant with those of other members of the ST3Gal subfamily, ablation of St3gal1 in mice causes a profound reduction in CD8 + T cells, indicating that the protein has a key role in the development and maintenance of the cytotoxic T-cell arm of the immune system 8 . As the first mammalian sialyltransferase structure to be reported, the structure of ST3Gal-I provides an opportunity to examine the relationship between homologous domains in the sialyltransferase family and their functions in catalyzing the synthesis of diverse sialoside sequences.
Several structural features of the mammalian sialyltransferase family have previously been deduced from their primary sequences 5 . All were known to have N-terminal signal anchor sequences that tether them to the Golgi membrane, and a flexible 'stem' region that is not required for catalytic activity (Fig. 1c,d) . Within the catalytic domain, several homologous regions have been identified, termed sialyl motifs, that were postulated to be involved in binding substrates and catalyzing the transfer of the sialic acid to the acceptor glycan 4, 5 . This new crystal structure includes the entire catalytic domain of a recombinant ST3Gal-I but lacks the N-terminal signal anchor and stem region. Structures were obtained bound to the acceptor or to donor substrate analogs, and these clearly identify the catalytic site (Fig. 1c) . The conserved sialyl n e w s a n d v i e w s
